The U.S. Food and Drug Administration (FDA) has authorized EpiEndo Pharmaceuticals to conduct a Phase 2a clinical trial of…
Teresa Carvalho, MS
Teresa holds her Master of Science in cell and molecular biology from Coimbra University, Portugal. She was a researcher and science communicator for several years at the Institute for Research and Innovation in Health in Oporto, Portugal. From 2013, she has held a fellowship working with Pulmonary Hypertension Europe as a patient advocate, social media/website manager, public relations officer, and translator. Her work has been focused on providing patients access to treatments, raising awareness for pulmonary hypertension, and promoting patient empowerment.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Teresa Carvalho, MS
Strados Labs has been awarded a $990,118 grant to advance the development of its RESP Smart Sensor Platform, a…
A new algorithm-based approach was developed to identify patients at risk of being misdiagnosed with chronic obstructive pulmonary disease…
A new, noninvasive breath biopsy panel — dubbed “a Breathalyzer for disease” — can distinguish several airway disorders, including…
A pilot study on the first wireless nebulizer for use by people with chronic obstructive pulmonary disease (COPD) has…
Royal Philips has launched a non-invasive ventilator, BiPAP A40 EFL, to remotely monitor patients with chronic obstructive pulmonary…
Training in the handling of inhaler devices improved treatment and eased clinical symptoms in older people with chronic obstructive…
The use of face masks does not cause intoxication induced by exhaled carbon dioxide (CO2), even in people with lung…
The COPD Foundation has launched the COPD360Net project to facilitate, assess, and accelerate clinical trials to further the…
Nebulized ensifentrine (RPL554) — which works both to widen the airways and as an anti-inflammatory — showed a significant…